Research Type: Academic Literature

Academic literature is reviewed by peer experts in a scientific field before it is approved for publication. The acceptance of our opinions and research after this vetting process indicates its relevance to current policies and other important drug and device issues.

  • Spending On Prescription Drugs In The US: Where Does All The Money Go?

    Spending On Prescription Drugs In The US: Where Does All The Money Go?

  • Money-Back Guarantees for Expensive Drugs: Wolf’s Clothing but a Sheep Underneath

    Money-Back Guarantees for Expensive Drugs: Wolf’s Clothing but a Sheep Underneath

  • Association of Rebates in Part D with Patient OOP and Federal Spending

    Association of Rebates in Part D with Patient OOP and Federal Spending

  • R&D Costs Do Not Explain Elevated U.S. Drug Prices

  • Value-Based Pricing for Drugs: Theme and Variations

    Value-Based Pricing for Drugs: Theme and Variations

  • Copay Assistance for Expensive Drugs: A Helping Hand That Raises Costs

  • Overspending Driven by Oversized Single Dose Vials of Cancer Drugs

    Overspending Driven by Oversized Single Dose Vials of Cancer Drugs

  • Pricing in the Market for Anticancer Drugs

  • The 340B Program: Hospitals Profit by Reaching Affluent Communities

  • The Just Price of Cancer Drugs